SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
86.40    2.40 (2.86%)
Bid:
86.00
Ask:
86.80
Spread: 0.80 (0.93%)
Market Cap: £242.10m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Q3 2024 Trading Update

24 Oct 2024 07:00

RNS Number : 3649J
Essentra plc
24 October 2024
 

ESSENTRA PLC

("Essentra", the "Group, or the "Company")

Q3 TRADING UPDATE

FY24 expectations in line with revised guidance

 

Essentra plc, a leading global provider and manufacturer of essential components and solutions, today provides a third quarter trading update for the thirteen weeks ended 28 September 2024 ("Q3" or the "period").

FY24 adjusted operating profit1 guidance is unchanged from the trading update released on 17 September 2024, and is aligned with market expectations2.

 

Trading update

Group revenue in Q3 reduced by 2.3% at constant currency, compared to the prior year period on a working day adjusted basis. Like-for-like3 ("LFL") revenue reduced by 5.8%, offset by a positive contribution to revenue of 3.5% from the acquisition of BMP s.r.l ("BMP TAPPI"), which completed in October 2023.

 

LFL revenue performance in Q3 was reflective of the weak manufacturing PMI metrics widely reported. EMEA (including Turkey) saw softening trading conditions whilst Americas reported slower than originally anticipated levels of recovery, although distributor volumes remained stable for another consecutive quarter. The APAC region delivered modest levels of growth, driven by a number of commercial business wins in faster growing end-markets from our China export business to the rest of Asia and Middle East.

 

Gross margins across all three regions remain strong, supported by good levels of cost control, procurement actions and operational efficiencies. When combined with Essentra's continued focus on its hassle-free customer proposition, the actions that have been taken over the last 18 months to right-size the cost base and optimise the business mean that the Group is well-positioned to benefit from material levels of operational gearing when normalised levels of volume return.

 

The Group's financial position is robust. FY24 leverage guidance is unchanged and is expected to be within the target range of 0.5x - 1.5x, providing a solid foundation from which the Group can continue to execute operational and strategic value-enhancing growth initiatives.

 

FY24 outlook unchanged

The Board expects FY24 adjusted operating profit to be in line with current market expectations. Trading in October supports the Group's revised internal forecasts, and Management remains focussed on delivering operational efficiencies in the near-term, whilst selectively investing for growth.

The underlying Essentra business model remains fundamentally strong, operating in a highly fragmented market combining the breadth and depth of its product offering, end-market capabilities and geographic footprint. Management continues to be confident that Essentra's robust and differentiated business model will support further progress towards its medium-term targets.

 

Notes

1. On a continuing operations basis, before amortisation of acquired intangible assets and adjusting items

2. Company compiled market expectations for 2024 adjusted operating profit is a range of £40.0m to £41.7m

3. The term "like-for-like" describes the performance of the continuing business on a comparable basis, adjusting for the impact of acquisitions, disposals and foreign exchange. 2024 LFL sales performance is adjusted for the acquisition of BMP s.r.l. ("BMP TAPPI") in October 2023

 

 

 

 

 

Enquiries

Essentra plc

Jack Clarke, Chief Financial Officer

Claire Goodman, Head of Investor Relations

Emma Reid, Company Secretary

 

Tel: +44 (0)1908 359100

FTI Consulting

Richard Mountain

Ariadna Peretz

 

FTI_essentra@fticonsulting.com

Tel: +44 (0)20 3727 1340

Notes to Editors

Essentra plc is a FTSE 250 company and a leading global provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra's global network extends to 28 countries worldwide and includes c.3,000 employees, 14 manufacturing facilities, 24 distribution centres and 33 sales & service centres serving c.69,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy. For further information, please visit www.essentraplc.com

LEI: 5493007MOZNA03BVNE96

Cautionary forward-looking statement

These results contain forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. The Company accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events of developments, whether as a result of new information, future events or otherwise, except to the extent legally required.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIRISLVFIS
Date   Source Headline
10th Jun 20269:47 amRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:32 pmRNSTransaction in Own Shares
21st May 202610:55 amRNSResult of AGM
20th May 20267:00 amRNSAcquisition of Boteco Srl
20th May 20267:00 amRNS2026 AGM Trading Update
14th May 20265:15 pmRNSDirector/PDMR Shareholding
12th May 20267:03 amRNSTransaction in Own Shares
1st May 202612:17 pmRNSTotal Voting Rights
29th Apr 20268:12 amRNSTransaction in Own Shares
28th Apr 20263:25 pmRNSDirector/PDMR Shareholding
24th Apr 20263:30 pmRNSDirector/PDMR Shareholding
22nd Apr 20268:15 amRNSTransaction in Own Shares
21st Apr 20264:09 pmRNSDirector/PDMR Shareholding
17th Apr 20267:52 amRNSHolding(s) in Company
15th Apr 202610:06 amRNSDirector/PDMR Shareholding
15th Apr 20268:24 amRNSTransaction in Own Shares
15th Apr 20268:18 amRNSHolding(s) in Company
9th Apr 20268:24 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSHolding(s) in Company
1st Apr 20264:45 pmRNSDirector/PDMR Shareholding
1st Apr 20263:21 pmRNSDirector/PDMR Shareholding
1st Apr 20263:15 pmRNSTransaction in Own Shares
1st Apr 20263:08 pmRNSTotal Voting Rights
30th Mar 20262:00 pmRNSAnnual Financial Report
24th Mar 202610:05 amRNSTransaction in Own Shares
24th Mar 20268:17 amRNSHolding(s) in Company
19th Mar 20268:43 amRNSDirector/PDMR Shareholding
17th Mar 20261:41 pmRNSDirector/PDMR Shareholding
17th Mar 202610:30 amRNSDirectorate change
17th Mar 202610:28 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
16th Mar 20269:40 amRNSTransaction in Own Shares
16th Mar 20269:40 amRNSTransaction in Own Shares
13th Mar 202612:00 pmRNSCompany Secretary Change
9th Mar 20269:00 amRNSNotice of Full Year 2025 Results
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:58 amRNSHolding(s) in Company
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202612:20 pmRNSHolding(s) in Company
17th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.